Skip to main content

Table 2 Subject characteristics

From: Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches

 

Overall

N = 32

Episodic migraine

N = 21

Chronic migraine

N = 11

Age (years), mean (SD)

40.3 (11.3)

39.7 (11.1)

41.5 (12.1)

Sex (female), n (%)

27 (84.4)

17 (81.0)

10 (90.1)

Ethnicity (not Hispanic or Latino), n (%)

28 (87.5)

17 (81.0)

11 (100)

Race, n (%)a

 White

26 (81.3)

17 (81.0)

9 (81.8)

 Black or African American

6 (18.8)

3 (14.3)

3 (27.3)

 American Indian or Alaska Native

2 (6.3)

1 (4.8)

1 (9.1)

 Other

1 (3.1)

0 (0)

1 (9.1)

Employment status, n (%)a

 Employed, full-time

19 (59.4)

15 (71.4)

4 (36.4)

 Employed, part-time

10 (31.3)

5 (23.8)

5 (45.5)

 Student

2 (6.3)

2 (9.5)

0 (0)

 Unemployed

1 (3.1)

0 (0)

1 (9.1)

 Other

1 (3.1)

0 (0)

1 (9.1)

Highest level of education, n (%)

 Secondary/high school

3 (9.4)

0 (0.0)

3 (27.3)

 Some college

14 (43.8)

10 (47.6)

4 (36.4)

 College degree

13 (40.6)

10 (47.6)

3 (27.3)

 Postgraduate degree

2 (6.3)

1 (4.8)

1 (9.1)

Migraine diagnosis duration (years), mean (SD)

14.3 (9.7)

12.2 (8.4)

18.5 (11.0)

Migraine interference with daily activities in past week, n (%)

 Not at all (0)

1 (3.1)

1 (4.8)

0 (0)

 Mildly (1–3)

5 (15.6)

2 (9.5)

3 (27.3)

 Moderately (4–6)

14 (43.8)

10 (47.6)

4 (36.4)

 Markedly (7–9)

9 (28.1)

6 (28.6)

3 (27.3)

 Extremely (10)

3 (9.4)

2 (9.5)

1 (9.1)

Did you miss work or school due to migraine related symptoms in the past week? n (%)

 Yes

9 (28.1)

7 (33.3)

2 (18.2)

 No

20 (62.5)

14 (66.7)

6 (54.6)

 I do not attend work or school

3 (9.4)

0 (0)

3 (27.3)

Treatments taken to treat migraines when they occur, n (%)a

 Over the counter/non-prescription medication

24 (75)

19 (90.5)

5 (45.6)

 Prescription drug

18 (56.3)

10 (47.6)

8 (72.7)

  1. aNot mutually exclusive